Printer Friendly

OWENS & MINOR, INC. ANNOUNCES RECORD FOURTH QUARTER AND TWELVE-MONTH NET INCOME FOR 1991

 OWENS & MINOR, INC. ANNOUNCES RECORD FOURTH QUARTER
 AND TWELVE-MONTH NET INCOME FOR 1991
 RICHMOND, Va., Feb. 4 /PRNewswire/ -- Owens & Minor, Inc. (NYSE: OMI) announced today its fourth quarter and twelve-month results. For the fourth quarter ended Dec. 31, 1991, sales were a record $352.4 million, up 11.4 percent from $316.3 million during the fourth quarter of 1990. Net income for the three-month period increased 25.5 percent to $3.5 million in 1991 from $2.8 million during the same period in 1990. Net income per share for the fourth quarter was $.27 as compared to $.22 for the same period in 1990, an increase of 22.7 percent.
 Sales for the twelve months ended Dec. 31, 1991 were a record $1.3 billion, an increase of 8.3 percent from the $1.2 billion level for the same period in 1990. Net income for the twelve-month period was $12.0 million as compared to $8.8 million for the same period in 1990, an increase of 37.1 percent. Net income per share for the twelve-month period was $.92 as compared to $.69 for the same twelve months in 1990, an increase of 33.3 percent.
 As previously announced on Jan. 17, 1992, Owens & Minor, Inc. has entered into a definitive agreement to sell substantially all of its wholesale drug business to Bergen Brunswig Corporation (AMEX: BBC) with closing, subject to regulatory approval, scheduled for Feb. 28, 1992. This sale upon completion will result in the elimination of the wholesale drug segment for reporting purposes.
 According to G. Gilmer Minor, III, President and CEO:
 "I am very pleased with our fourth quarter and year-end results. This has been a year during which we have put together the combination of a superlative effort by our team of employees and a growing recognition of our value in the marketplace by our customers and suppliers to achieve record results. Improvement over the prior year was evident in every major financial category. Of particular note, we accomplished our goal of increasing our gross margin, not necessarily by raising prices but by controlling our business more effectively and managing our inventory to take better advantage of our size in the marketplace. We have been proactive in developing a number of partnerships with our customers as well as suppliers that are designed to improve efficiency and lower cost in the supply chain. We are a leader in this regard within our industry. The acquisition of Koley's Medical Supply in Omaha and Kearney, Nebraska and Des Moines, Iowa was completed on December 2, 1991, and gives us further penetration of the Midwest. The announced signing of a definitive agreement with Bergen Brunswig Corporation to sell substantially all of our wholesale drug business is a major step for the Company that will strengthen our balance sheet, improve profitability and allow us to move aggressively to enhance our position as the second largest medical/surgical distributor in the country. I am very excited about our prospects for 1992 as we continue to change and move forward at an accelerated pace.
 OPERATING RESULTS
 (Unaudited)
 (In thousands, except per share data)
 Three Months Ended Percentage
 December 31, Change
 1991 1990
 Net sales $ 352,371 $ 316,295 11.4
 Net income $ 3,501 $ 2,790 25.5
 Net income per
 common share $ .27 $ .22 22.7
 Weighted average common
 shares and common
 share equivalents 13,173 12,830 2.7
 Twelve Months Ended Percentage
 December 31, Change
 1991 1990
 Net sales $1,320,438 $1,219,617 8.3
 Net income $ 12,027 $ 8,775 37.1
 Net income per
 common share $ .92 $ .69 33.3
 Weighted average common
 shares and common
 share equivalents 13,094 12,780 2.5
 All EPS amounts have been restated for the 3 for 2 stock split announced on June 20, 1991, that was distributed July 16, 1991 to shareholders of record as of July 2, 1991.
 Owens & Minor, Inc. is a wholesale distributor of medical and surgical supplies, pharmaceuticals and other related products. Through its Vangard Labs subsidiary, the Company also packages generic and brand name pharmaceuticals.
 -0- 2/4/92
 /CONTACT: Glenn J. Dozier, Senior Vice President, Operations and Systems, Chief Financial Officer, Owens & Minor, Inc., 804-965-2945/
 (OMI BBC) CO: Owens & Minor, Inc.; Bergen Brunswig Corporation ST: Virginia IN: MTC SU: ERN


CM-JZ -- CH002 -- 6645 02/04/92 11:28 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 4, 1992
Words:731
Previous Article:PEACH BOTTOM SIREN TEST SCHEDULED FEB. 5
Next Article:J. B. HUNT TRANSPORT SERVICES REPORTS REVENUES AND EARNINGS FOR FOURTH QUARTER 1991
Topics:


Related Articles
OWENS & MINOR, INC. ANNOUNCES RECORD FOURTH QUARTER AND TWELVE-MONTH NET INCOME FOR 1991
OWENS & MINOR, INC. ANNOUNCES RECORD 1992 FOURTH QUARTER AND TWELVE-MONTH EARNINGS FROM CONTINUING OPERATIONS
OWENS & MINOR, INC., ANNOUNCES IMPROVED 1993 SECOND QUARTER AND SIX-MONTH EARNINGS
OWENS & MINOR, INC., ANNOUNCES IMPROVED 1993 THIRD QUARTER AND NINE-MONTH EARNINGS
OWENS & MINOR, INC. ANNOUNCES RECORD 1993 FOURTH QUARTER AND TWELVE-MONTH EARNINGS FROM CONTINUING OPERATIONS
OWENS & MINOR ANNOUNCES 1994 FOURTH QUARTER AND TWELVE-MONTH EARNINGS
INESS EDITOR:
Owens & Minor Announces Third Quarter Results - Quarterly Sales Hit Highest Level in Company History And Net Income Rises 8 Percent.
/C O R R E C T I O N -- Owens & Minor/.
Owens & Minor Reports EPS Up 25 Percent and Sales Up 20 Percent For 4th Quarter 1999, Capping a Record-Breaking Year.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters